Loading...
Loading...
By Sofía Garduño - Fri, 10/25/2024 - 12:17
Mexico could improve rare disease care by increasing healthcare investment and adopting a multidisciplinary approach, says BioMarin’s David López.
https://mexicobusiness.news/tag/biomarin
More Talent
By MBN Staff - Tue, 09/03/2024 - 09:03
BioMarin cuts 225 jobs in a global reorganization after halting gene therapy developments and implementing strategic shifts.
By Sofía Garduño - Tue, 01/30/2024 - 09:52
Navigating the evolving tech landscape poses challenges for biotech talent acquisition, driven by demand for specialized skills.
By Miriam Bello - Fri, 08/27/2021 - 13:18
The European Commission approved the use of Biomarin’s treatment for achondroplasia, one of the most common forms of dwarfism.
By Miriam Bello - Thu, 02/11/2021 - 09:00
Moving the focus of healthcare from sickness treatment to sustained health demands disruption and structural change.
By Miriam Bello - Tue, 08/25/2020 - 13:49
In healthcare, time is gold. How much longer can patients wait for treatments due to COVID-19?
By Miriam Bello - Fri, 07/03/2020 - 14:06
Pharmaceutical industry leaders share their views on the “payment by results” method to increase healthcare access.
By - Fri, 09/20/2019 - 09:40
Timely and comprehensive patient care is the central axis for improving quality of life.
By - Tue, 03/12/2019 - 18:33
BioMarin Pharmaceuticals is a biotechnology company developing and commercializing innovative biopharmaceuticals for rare genetic diseases.
By - Wed, 09/06/2017 - 10:30
Rare diseases are often difficult to treat because developing medications for them is costly for manufacturers
